AstraZeneca COVID-19 antibody drug offers 83% protection over six months
These new data add to the growing body of evidence supporting AZD7442's potential to make a significant difference in the prevention and treatment of COVID-19
Thu Nov 18 2021
AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine ops
Antibody drug AZD7442 was shown to prevent COVID-19 in a trial.
Fri Aug 20 2021
Dual-antibody drugs effective against COVID-19 variants in animal study
The latest study found that combinations of two antibodies often retained potency against variants.
Tue Jun 22 2021
U.S. FDA gives emergency use approval for GSK-Vir COVID-19 antibody drug
Sotrovimab, is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy.
Wed May 26 2021
New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code
Here's a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.
Tue May 11 2021